Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Keaney

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Circulation|October 26, 2005
Oxidative stress and the vascular wall: NADPH oxidases take center stageJohn F Keaney
Circulation|November 30, 2011
Immune modulation of atherosclerosisJohn F Keaney
The New England Journal of Medicine|March 17, 2015
Balancing the risks and benefits of dual platelet inhibitionJohn F Keaney
The New England Journal of Medicine|March 6, 2023
Bempedoic Acid and the Prevention of Cardiovascular DiseaseJohn F Keaney
The New England Journal of Medicine|June 22, 2017
CHIP-ping Away at AtherosclerosisJohn F Keaney
Circulation|August 10, 2005
Circulating biomarkers in acute coronary syndromes: something different or more of the same?John F Keaney
The New England Journal of Medicine|September 3, 2013
P2Y12 inhibition in patients with NSTEMI--can later be better?John F Keaney
Physiological Reviews|September 24, 2004
Role of oxidative modifications in atherosclerosisRoland Stocker, John F Keaney
Current Opinion in Pharmacology|January 12, 2010
AMP-activated protein kinase: a stress-responsive kinase with implications for cardiovascular diseaseChunying Li, John F Keaney
Circulation|January 28, 2015
Joseph A. Vita, MD, 1956-2014John F Keaney, Joseph Loscalzo
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Circulation|October 26, 2005
Oxidative stress and the vascular wall: NADPH oxidases take center stageJohn F Keaney
Circulation|November 30, 2011
Immune modulation of atherosclerosisJohn F Keaney
The New England Journal of Medicine|March 17, 2015
Balancing the risks and benefits of dual platelet inhibitionJohn F Keaney
The New England Journal of Medicine|March 6, 2023
Bempedoic Acid and the Prevention of Cardiovascular DiseaseJohn F Keaney
The New England Journal of Medicine|June 22, 2017
CHIP-ping Away at AtherosclerosisJohn F Keaney
Circulation|August 10, 2005
Circulating biomarkers in acute coronary syndromes: something different or more of the same?John F Keaney
The New England Journal of Medicine|September 3, 2013
P2Y12 inhibition in patients with NSTEMI--can later be better?John F Keaney
Physiological Reviews|September 24, 2004
Role of oxidative modifications in atherosclerosisRoland Stocker, John F Keaney
Current Opinion in Pharmacology|January 12, 2010
AMP-activated protein kinase: a stress-responsive kinase with implications for cardiovascular diseaseChunying Li, John F Keaney
Circulation|January 28, 2015
Joseph A. Vita, MD, 1956-2014John F Keaney, Joseph Loscalzo
Pageof 18